Cancer stem cell self-renewal as a therapeutic target in human oral cancer.

Abstract:

:Tumor recurrence following treatment remains a major clinical challenge in oral cavity cancer. Cancer stem cells (CSCs) have been isolated from human oral cancers and been considered as the driving force of tumor recurrence and metastasis. However, it still remains unclear whether targeting CSCs in oral cancer is a clinically relevant strategy to combat cancer recurrence and metastasis. Here, using clinical cancer specimens and patient-derived xenografts, we show that the self-renewal regulator BMI1 is highly expressed in CSCs of oral cavity squamous cell carcinoma. Inhibition of BMI1 decreases oral CSCs' self-renewal and tumor-initiating potential. Treatment of pre-established human oral cancer xenografts with a BMI1 inhibitor resulted in abrogation of tumor progression and reduced the frequency of CSCs in the xenografts. Remarkably, the BMI1 inhibitor has therapeutic effects in cisplatin-resistant tumors and can reduce metastases initiated by circulating CSCs. Mechanistically, BMI1-inhibition leads to oral CSC necroptotic cell death, which underlies the self-renewal impairment after inhibiting BMI1. Our data provide a pre-clinical proof-of-concept that targeting BMI1-related CSC self-renewal is a clinically relevant anti-cancer therapy in human oral cavity squamous cell carcinoma.

journal_name

Oncogene

journal_title

Oncogene

authors

Hu J,Mirshahidi S,Simental A,Lee SC,De Andrade Filho PA,Peterson NR,Duerksen-Hughes P,Yuan X

doi

10.1038/s41388-019-0800-z

subject

Has Abstract

pub_date

2019-07-01 00:00:00

pages

5440-5456

issue

27

eissn

0950-9232

issn

1476-5594

pii

10.1038/s41388-019-0800-z

journal_volume

38

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • ISL2 modulates angiogenesis through transcriptional regulation of ANGPT2 to promote cell proliferation and malignant transformation in oligodendroglioma.

    abstract::Oligodendroglioma is an important type of lower-grade glioma (LGG), which is a slowly progressing brain tumor. Many LGGs eventually transform into a more aggressive or malignant type. Enhanced angiogenesis is a characteristic of malignantly transformed oligodendroglioma (m-oligodendroglioma). However, the pathogenesis...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01411-y

    authors: Qi L,Wang ZY,Shao XR,Li M,Chen SN,Liu XQ,Yan S,Zhang B,Zhang XD,Li X,Zhao W,Pan JA,Zhao B,Zhang XD

    更新日期:2020-09-01 00:00:00

  • Amplification of 11q13 DNA sequences in human breast cancer: D11S97 identifies a region tightly linked to BCL1 which can be amplified separately.

    abstract::In the course of our study on the amplification of 11q13 sequences in human breast cancer, we have investigated the amplification status of the anonymous DNA fragment D11S97 in a series of 125 mammary tumors. Our results indicate that, as with bladder carcinomas, D11S97 can be amplified separately from BCL1. In additi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Szepetowski P,Courseaux A,Carle GF,Theillet C,Gaudray P

    更新日期:1992-04-01 00:00:00

  • Activation and repression of p21(WAF1/CIP1) transcription by RB binding proteins.

    abstract::The Cdk inhibitor p21(WAF1/CIP1) is a negative regulator of the cell cycle, although its expression is induced by a number of mitogens that promote cell proliferation. We have found that E2F1 and E2F3, transcription factors that activate genes required for cell cycle progression, are strong activators of the p21 promo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202240

    authors: Gartel AL,Goufman E,Tevosian SG,Shih H,Yee AS,Tyner AL

    更新日期:1998-12-31 00:00:00

  • Anthracyclines induce the accumulation of mutant p53 through E2F1-dependent and -independent mechanisms.

    abstract::Mutant p53 frequently accumulates in cancer cells and promotes tumor cell invasion, as part of its gain of function. Its accumulation is partially due to enhanced stability, but little is known about how the mRNA levels of mutant p53 can be regulated. Likewise, the impact of cancer therapy on the levels of mutant p53 ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.72

    authors: Bug M,Dobbelstein M

    更新日期:2011-08-18 00:00:00

  • How asbestos drives the tissue towards tumors: YAP activation, macrophage and mesothelial precursor recruitment, RNA editing, and somatic mutations.

    abstract::Chronic exposure to intraperitoneal asbestos triggered a marked response in the mesothelium well before tumor development. Macrophages, mesothelial precursor cells, cytokines, and growth factors accumulated in the peritoneal lavage. Transcriptome profiling revealed YAP/TAZ activation in inflamed mesothelium with furth...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0153-z

    authors: Rehrauer H,Wu L,Blum W,Pecze L,Henzi T,Serre-Beinier V,Aquino C,Vrugt B,de Perrot M,Schwaller B,Felley-Bosco E

    更新日期:2018-05-01 00:00:00

  • Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1α mediated by the PTEN/PI3K/Akt pathway.

    abstract::Mel-18 has been implicated in several processes in tumor progression, in which the Akt pathway is involved as an important key molecular event. However, the function of Mel-18 in human cancers has not been fully established yet. Here, we examined the effect of Mel-18 on tumor angiogenesis in human breast cancer, and f...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.174

    authors: Park JH,Lee JY,Shin DH,Jang KS,Kim HJ,Kong G

    更新日期:2011-11-10 00:00:00

  • MicroRNA dysregulation in gastric cancer: a new player enters the game.

    abstract::Gastric carcinogenesis is a multistep process involving genetic and epigenetic alteration of protein-coding proto-oncogenes and tumor-suppressor genes. Recent discoveries have shed new light on the involvement of a class of noncoding RNA known as microRNA (miRNA) in gastric cancer. A substantial number of miRNAs show ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2010.352

    authors: Wu WK,Lee CW,Cho CH,Fan D,Wu K,Yu J,Sung JJ

    更新日期:2010-10-28 00:00:00

  • Characterization of p73 functional domains necessary for transactivation and growth suppression.

    abstract::p73, a p53 family member, is highly similar to p53 in both structure and function. Like p53, the p73 protein contains an N-terminal activation domain, a DNA-binding domain, a tetramerization domain, and several PXXP motifs. Previously, we and others have shown that some functional domains in p53, such as the DNA-bindi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206470

    authors: Nozell S,Wu Y,McNaughton K,Liu G,Willis A,Paik JC,Chen X

    更新日期:2003-07-10 00:00:00

  • Direct cancer tissue proteomics: a method to identify candidate cancer biomarkers from formalin-fixed paraffin-embedded archival tissues.

    abstract::Successful treatment of multiple cancer types requires early detection and identification of reliable biomarkers present in specific cancer tissues. To test the feasibility of identifying proteins from archival cancer tissues, we have developed a methodology, termed direct tissue proteomics (DTP), which can be used to...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209755

    authors: Hwang SI,Thumar J,Lundgren DH,Rezaul K,Mayya V,Wu L,Eng J,Wright ME,Han DK

    更新日期:2007-01-04 00:00:00

  • p53-independent association between SV40 large T antigen and the major cytosolic heat shock protein, HSP90.

    abstract::The simian double strand DNA tumor virus SV40 encodes the 90-kDa multi-functional protein, large T antigen (LT). LT functions by binding to DNA, as well as to many cellular target proteins such as p53 and retinoblastoma protein (pRB). We report here the identification of a cellular heat shock protein, HSP90, as a prev...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203475

    authors: Miyata Y,Yahara I

    更新日期:2000-03-09 00:00:00

  • The C terminus of the synovial sarcoma-associated SSX proteins interacts with the LIM homeobox protein LHX4.

    abstract::As a result of the synovial sarcoma-associated t(X;18) translocation, the SS18 gene on chromosome 18 is fused to either one of the three closely related SSX genes on the X chromosome. The SS18 protein is thought to act as a transcriptional co-activator, whereas the SSX proteins are thought to act as transcriptional co...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210688

    authors: de Bruijn DR,van Dijk AH,Willemse MP,van Kessel AG

    更新日期:2008-01-24 00:00:00

  • Identification of p53 genetic suppressor elements which confer resistance to cisplatin.

    abstract::Loss of p53 function is associated with the acquisition of cisplatin resistance in the human ovarian adenocarcinoma A2780 cell line. Selection for cisplatin resistance of A2780 cells was used to isolate genetic suppressor elements (GSEs) from a retroviral library expressing random fragments of human or murine TP53 cDN...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1200813

    authors: Gallagher WM,Cairney M,Schott B,Roninson IB,Brown R

    更新日期:1997-01-16 00:00:00

  • Correlation between the conformational phenotype of p53 and its subcellular location.

    abstract::In order to obtain insight into the parameters determining the subcellular localization of mutant and wild-type forms of p53, we analysed the subcellular distribution of p53 in four Balb/c mouse-derived cell lines ranging in their cellular phenotypes from normal (3T3), via minimal transformant (T3T3), to maximally tra...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Zerrahn J,Deppert W,Weidemann D,Patschinsky T,Richards F,Milner J

    更新日期:1992-07-01 00:00:00

  • Apolipoprotein C-1 maintains cell survival by preventing from apoptosis in pancreatic cancer cells.

    abstract::Pancreatic cancer still remains one of the most lethal diseases and establishment of new therapy is needed. The purpose of this study is to find novel factors involved in pancreatic cancer progression by proteomic approach. We compared pre- and postoperative serum protein profiling obtained from pancreatic cancer pati...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210951

    authors: Takano S,Yoshitomi H,Togawa A,Sogawa K,Shida T,Kimura F,Shimizu H,Tomonaga T,Nomura F,Miyazaki M

    更新日期:2008-05-01 00:00:00

  • EBP1 is a nucleolar growth-regulating protein that is part of pre-ribosomal ribonucleoprotein complexes.

    abstract::EBP1 was identified as a protein that interacts with the ErbB-3 receptor and possibly contributes to transducing growth regulatory signals. The existence of EBP1 homologs across species from simple eukaryotes to humans and its wide tissue expression pattern suggest that EBP1 acts as a general signaling molecule. We pr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207579

    authors: Squatrito M,Mancino M,Donzelli M,Areces LB,Draetta GF

    更新日期:2004-05-27 00:00:00

  • The natural protein kinase C alpha mutant is present in human thyroid neoplasms.

    abstract::An altered protein expression of Ca(2+)-dependent protein kinase C (PKC) isoforms and a point mutation in the PKC alpha cDNA (position 908 of the nucleotide sequence, position 294 of the amino acid sequence, substitution of an aspartic acid by a glycine) have been previously described in a subpopulation of human pitui...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Prévostel C,Alvaro V,de Boisvilliers F,Martin A,Jaffiol C,Joubert D

    更新日期:1995-08-17 00:00:00

  • Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.

    abstract::Human papillomaviruses (HPVs) are involved in the pathogenesis of cancer of the cervix (CaCx). MicroRNA (miRNA) expression analysis using Ambion (Austin, TX, USA) arrays showed that three miRNAs were overexpressed and 24 underexpressed in cervical cell lines containing integrated HPV-16 DNA compared to the normal cerv...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210919

    authors: Martinez I,Gardiner AS,Board KF,Monzon FA,Edwards RP,Khan SA

    更新日期:2008-04-17 00:00:00

  • p53 represses SV40 transcription by preventing formation of transcription complexes.

    abstract::There is now much evidence to suggest that the p53 tumour suppressor protein functions to monitor the integrity of the genome. When DNA damage is detected, p53 suppresses cell growth to allow repair or directs the cell into apoptosis. The mechanism of action of p53 is as yet unclear but recent evidence has accumulated...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Perrem K,Rayner J,Voss T,Sturzbecher H,Jackson P,Braithwaite A

    更新日期:1995-10-05 00:00:00

  • PKCmu prevents CD95-mediated apoptosis and enhances proliferation in pancreatic tumour cells.

    abstract::Loss of growth control and a marked resistance to apoptosis are considered major mechanisms driving tumour progression. Protein kinases C (PKC) have been shown to be important in the regulation of proliferation and apoptosis. In this report, we investigated the role of the PKC-like kinase PKCmu in the control of these...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207001

    authors: Trauzold A,Schmiedel S,Sipos B,Wermann H,Westphal S,Röder C,Klapper W,Arlt A,Lehnert L,Ungefroren H,Johannes FJ,Kalthoff H

    更新日期:2003-12-04 00:00:00

  • Novel synthetic bisindolylmaleimide alkaloids inhibit STAT3 activation by binding to the SH2 domain and suppress breast xenograft tumor growth.

    abstract::Signal transducer and activator of transcription 3 (STAT3) is constitutively activated in malignant tumors and plays important roles in multiple aspects of cancer aggressiveness. Thus, targeting STAT3 promises to be an attractive strategy for the treatment of advanced metastatic tumors. Bisindolylmaleimide alkaloid (B...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-017-0076-0

    authors: Li X,Ma H,Li L,Chen Y,Sun X,Dong Z,Liu JY,Zhu W,Zhang JT

    更新日期:2018-05-01 00:00:00

  • Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions.

    abstract::The breast cancer susceptibility gene 1 (BRCA1) is mutated in approximately 50% of hereditary breast cancers, and its expression is decreased in 30-40% of sporadic breast cancers, suggesting a general role in breast cancer development. BRCA1 physically and functionally interacts with estrogen receptor-alpha (ERalpha) ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.405

    authors: Wen J,Li R,Lu Y,Shupnik MA

    更新日期:2009-01-29 00:00:00

  • Glypican-3 expression is silenced in human breast cancer.

    abstract::Glypican-3 (GPC3) is a membrane-bound heparan sulfate proteoglycan that is mutated in the Simpson-Golabi-Behmel syndrome. This is an X-linked condition characterized by overgrowth, and various visceral and skeletal dysmorphisms. The phenotype of the Simpson-Golabi-Behmel syndrome patients and GPC3-deficient mice, as w...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204925

    authors: Xiang YY,Ladeda V,Filmus J

    更新日期:2001-11-01 00:00:00

  • The DNA-damage response and nuclear events as regulators of nonapoptotic forms of cell death.

    abstract::The maintenance of genome stability is essential for the cell as the integrity of genomic information guaranties reproduction of a whole organism. DNA damage occurring in response to different natural and nonnatural stimuli (errors in DNA replication, UV radiation, chemical agents, etc.) is normally detected by specia...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/s41388-019-0980-6

    authors: Prokhorova EA,Egorshina AY,Zhivotovsky B,Kopeina GS

    更新日期:2020-01-01 00:00:00

  • Stimulation of the mitogen-activated protein kinase pathway antagonizes TRAIL-induced apoptosis downstream of BID cleavage in human breast cancer MCF-7 cells.

    abstract::We studied the role of the mitogen-activated protein kinase (MAPK) pathway in the regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in breast tumor MCF-7 cells. We found that addition of a protein kinase C (PKC) activator to MCF-7 cultures prevented TRAIL-induced apoptosi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205523

    authors: Sarker M,Ruiz-Ruiz C,Robledo G,López-Rivas A

    更新日期:2002-06-20 00:00:00

  • Retinoid-dependent antagonism of serum response factor transactivation mediated by transcriptional coactivator proteins.

    abstract::Transcriptional coactivators SRC-1 and p300 specifically interact with liganded-nuclear receptors and also modulate other transcription factors, including serum response factor (SRF). Here, we report that retinoids repress transactivation by SRF and specific interactions exist between the DNA binding domains of SRF an...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204695

    authors: Kim SW,Kim HJ,Jung DJ,Lee SK,Kim YS,Kim JH,Kim TS,Lee JW

    更新日期:2001-10-04 00:00:00

  • Enhanced EGF mitogenic response is associated with enhanced tyrosine phosphorylation of specific cellular proteins in fibroblasts overexpressing c-src.

    abstract::In previous studies examining the role of pp60c-src in cellular proliferation, we demonstrated that overexpression of wild type (wt) but not mutated c-src in C3H10T1/2 murine embryo fibroblasts resulted in a 2 to 5 fold enhancement of DNA synthesis in response to epidermal growth factor (EGF). Using phosphotyrosine an...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Wilson LK,Parsons SJ

    更新日期:1990-10-01 00:00:00

  • p53/BNIP3-dependent mitophagy limits glycolytic shift in radioresistant cancer.

    abstract::The role of p53 in genotoxic therapy-induced metabolic shift in cancers is not yet known. In this study, we investigated the role of p53 in the glycolytic shift in head and neck squamous cell carcinoma cell lines following irradiation. Isogenic p53-null radioresistant cancer cells established through cumulative irradi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0697-6

    authors: Chang HW,Kim MR,Lee HJ,Lee HM,Kim GC,Lee YS,Nam HY,Lee M,Jang HJ,Lee KE,Lee JC,Byun Y,Kim SW,Kim SY

    更新日期:2019-05-01 00:00:00

  • The consistent 13q14 translocation breakpoint seen in chronic B-cell leukaemia (BCLL) involves deletion of the D13S25 locus which lies distal to the retinoblastoma predisposition gene.

    abstract::Structural rearrangements involving chromosome 13 are frequently seen in B-cell chronic lymphocytic leukaemia. The presence of reciprocal translocations involving 13q14 in 10-15% of cases pinpoints the location of a gene important in leukaemogenesis. In order to characterise the exact location of the 13q14 breakpoint,...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Hawthorn LA,Chapman R,Oscier D,Cowell JK

    更新日期:1993-06-01 00:00:00

  • Lessons learned from BRCA1 and BRCA2.

    abstract::BRCA1 and BRCA2 are breast cancer susceptibility genes. Mutations within BRCA1 and BRCA1 are responsible for most familial breast cancer cases. Targeted deletion of Brca1 or Brca2 in mice has revealed an essential function for their encoded products, BRCA1 and BRCA2, in cell proliferation during embryogenesis. Mouse m...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1203968

    authors: Zheng L,Li S,Boyer TG,Lee WH

    更新日期:2000-12-11 00:00:00

  • Elevated Mdm2 expression induces chromosomal instability and confers a survival and growth advantage to B cells.

    abstract::Mdm2, a regulator of the p53 tumor suppressor, is frequently overexpressed in lymphomas, including lymphomas that have inactivated p53. However, the biological consequences of Mdm2 overexpression in lymphocytes are not fully resolved. Here, we report that increased expression of Mdm2 in B cells augmented proliferation...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210788

    authors: Wang P,Lushnikova T,Odvody J,Greiner TC,Jones SN,Eischen CM

    更新日期:2008-03-06 00:00:00